Libero Thera logo

Libero Thera

Delivering advanced drug discovery and development services, specializing in GPCRs for membrane proteins since 2018, based in Tokyo.

est. 2018

VS
TScan Therapeutics logo

TScan Therapeutics

Unleash Immunity

152 employees · est. 2018 · Waltham, United States

Side-by-Side Comparison

Libero Thera TScan Therapeutics
Founded
2018 2018
Headquarters
Not tracked yet Waltham, United States
Employees
Not tracked yet 152
Industry
Biopharma, Biotechnology, Life Sciences Biotechnology, Health Care, Health and Wellness
Funding Stage
Series Unknown IPO
Total Funding
$535.00M $662.60M
Funding Rounds
1 9
Services
Not tracked yet Development of T-cell therapies, Genetically reprogramming T cells, Clinical trials for TCR-T therapy candidates, Anti-cancer TCR discovery
Target Customers
Not tracked yet Cancer patients, Patients with hematologic malignancies, Patients with solid tumors, Patients with autoimmune diseases
Taxonomy
Drug Discovery, Development Services, GPCRs, Membrane Proteins, Pharmaceuticals, Tokyo, Biopharmaceuticals TCR-T Cell Therapy, T Cell Therapies, Biopharmaceutical, Hematologic Malignancies, Solid Tumors, Residual Leukemia, Hematopoietic Stem Cell Transplantation, Engineered T Cell Therapy, Automimmune Disorders, Infectious Diseases, Multiplexed Therapy, Oncology, Immune System, Therapeutic Platforms, Life Sciences Innovation
Website
liberothera.com tscan.com
Libero Thera logo

About Libero Thera

Libero Thera, **founded in 2018**, is a biopharma and biotechnology company based in Tokyo, Japan. The company specializes in **delivering advanced drug discovery and development services**, with a focus on drugs involving GPCRs for membrane proteins. In May 2021, the company secured a significant *...

TScan Therapeutics logo

About TScan Therapeutics

TScan Therapeutics, founded in 2018 and headquartered in the United States, specializes in pioneering T cell therapies aimed at tapping into the full potential of the human immune system. The company's slogan, "Unleash Immunity," reflects its dedication to developing life-changing therapeutics. Ren...

We will tell you when either one moves

BounceWatch watches Libero Thera and TScan Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Libero Thera and TScan Therapeutics — by email.

Frequently Asked Questions

Libero Thera — Delivering advanced drug discovery and development services, specializing in GPCRs for membrane proteins since 2018, based in Tokyo.. TScan Therapeutics — Unleash Immunity. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Libero Thera has raised $535.00M while TScan Therapeutics has raised $662.60M.
Libero Thera and TScan Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Libero Thera with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Libero Thera on 12 Sep 2024, and TScan Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes